---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-001196"
form_type: "8-K"
ticker: "CLNN"
cik: "0001822791"
company_name: "Clene Inc."
filed_at: "2026-01-13T23:59:59+00:00"
generated_at: "2026-05-16T10:41:57.633814+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Clene raises $28M in registered direct offering from Boxer, Coastlands, Vivo Capital

## Summary
- Offering totals $28M in three tranches; initial $6.03M closed Jan 13, 2026 at $6.50/unit.
- Additional tranches: $6.7M Series A warrants contingent on PDUFA date, $15.6M Series B on FDA approval.
- Warrants exercise price adjustable based on stock price milestones; redeemable if in-the-money.
- Investors include Boxer Capital, Coastlands Capital, Vivo Capital; BTIG as sole placement agent.
- Proceeds expected to fund operations into early 2027, supporting NDA and potential CNM-Au8 commercialization in ALS.

## SEC filing metadata
- accession: 0001437749-26-001196
- form_type: 8-K
- ticker: CLNN
- cik: 0001822791
- company_name: Clene Inc.
- filed_at: 2026-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822791/000143774926001196/0001437749-26-001196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822791/000143774926001196/clnn20260106_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-001196
- JSON: https://secwatch.observer/filing/0001437749-26-001196.json
- Plain text: https://secwatch.observer/filing/0001437749-26-001196.txt

## Key facts
- Material Agreements
  Clene Inc. entered into Securities Purchase Agreement with certain institutional investors, existing stockholders of the Company, and certain of the Company's directors valued at $6.50 per unit (effective 2026-01-08).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors, existing stockholders of the Company, and certain of the Company's directors
  - Value: $6.50 per unit
  - Effective: 2026-01-08
  source text: On January 8, 2026, Clene Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain institutional investors, existing stockholders of the Company, and certain of the Company’s directors for the sale of (i) 928,333 shares of the Company’s common stock, par value $0.0001 per share (“common stock”), (ii) warrants to purchase up to 1,114,000 shares of the Company’s common stock (the “Series A Warrants”) and (iii) warrants to purchase up to 2,599,333 shares of the Company’s common stock (the “Series B Warrants,” and together with the Series A Warrants, the “Warrants”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822791/000143774926001196/0001437749-26-001196-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.